Where is ATDC's headquarters located?

ATDC's headquarters is located in Atlanta (United States).

How big is ATDC's investment team?

ATDC has a team of 29, including 6 partners.

How many companies has ATDC invested in?

ATDC has invested in 9 companies, including Iconic Therapeutics & UserIQ.

Which companies has ATDC invested in lately?

AvantiCure & MapHabit are the latest investments by ATDC.

How many exits has ATDC been involved in?

ATDC's portfolio has seen 1 IPO and 1 acquisition.

ATDC - 2026 Investor Profile, Portfolio, Team & Investment Trends

ATDC, an accelerator and incubator program founded in 1980, is based in Atlanta, United States. With a presence in 1 country, it has supported around 9 startups in sectors like Enterprise Applications, Life Sciences. As of Jul 2026, ATDC has witnessed 2 portfolio exits. Most notable companies in its portfolio include Iconic Therapeutics, UserIQ and VTI. The program is backed by a team of 29 people who primarily support Seed startups based in United States. Its latest investment was a $50K Grant (prize money) round in AvantiCure on Aug 12, 2019.

Key Metrics

Founded Year

1980

Location

Atlanta, United States

Portfolio Companies

Iconic Therapeutics, UserIQ & 7 more

Sectors of Investment

Enterprise Applications, Life Sciences & 10 more

Stages of Investment

Seed, Series A & 3 more

Locations of Investment

United States

View ATDC's full profile

ATDC has a portfolio of 9 companies. Their most notable investments are in MapHabit and iVivity.Their portfolio spans across and United States. They have invested in Enterprise Applications, Life Sciences, HealthTech and 9 other sectors, across stages such as Seed, Series A and 3 more. Here is the list of top investments by ATDC:

1. Iconic Therapeutics

Iconic Therapeutics is dedicated to translating an understanding of the role of Tissue Factor (TF) biology to new therapeutics for retinal disease and cancer. Its lead product candidate, ICON-1, is a novel fusion protein designed to address the basis of vision loss in Age-related Macular Degeneration (AMD). When ICON-1 binds to cells that aberrantly overexpress TF, it signals the body’s immune system to remove the pathologic tissue, while leaving normal blood vessels and organ functions intact. The company is also investigating the ICON family of proteins in cancer and has initiated a research program in solid tumors.

Key facts about Iconic Therapeutics

Founded Year: 2002
Location: San Francisco (United States)
Stage: Acquired
Total Funding till date: $105M
Investors: HBM Healthcare Investments, Lundbeck Foundation and 8 Others
Latest Funding Round: Series C, Apr 26, 2019, $*****
Highlight: Acquired

2. UserIQ

Provider of tools for customer health predictions for customer success teams. It tracks and analyzes visitors in app behavior and creates automated interactions such as messages, special features, and offers, surveys and guided tours, based on customer behavior. Target users with segments based on behavior and persona by using psychographic data from CRM tools like Salesforce.

Key facts about UserIQ

Founded Year: 2014
Location: Dunwoody (United States)
Stage: Deadpooled
Total Funding till date: $9.65M
Employee Count: 3 as on Apr 30, 2026
Investors: Tech Square Ventures, Southeast Investor Group and 7 Others
Latest Funding Round: Series A, Dec 15, 2021, $*****

3. VTI

Innovative eye care redefining vision with advanced contact lens technology. The company is dedicated to redefining vision care through revolutionary solutions for presbyopia, myopia, and astigmatism. It designs, manufactures, sells, and distributes contact lenses globally, focusing on markets with high vision demands. The company fosters scientific advancement to improve human health and quality of life, promoting collaboration, respect, and integrity. It offers NaturalVue brand contact lenses, including enhanced multifocal and sphere options, indicated for daily wear to correct refractive ametropia. The company is committed to innovation and expanding its reach to address vision care needs worldwide.

Key facts about VTI

Founded Year: 2008
Location: Alpharetta (United States)
Stage: Public
Total Funding till date: $5M
Employee Count: 28 as on May 31, 2026
Investors: Charter Life Sciences, ATDC and 2 Others
Latest Funding Round: Post IPO, Dec 30, 2019, $*****
Highlight: Public

4. MapHabit

MapHabit provides wearable devices with an app for people with mental disorders like Alzheimer's. It gives reminders and spoken commands. The app also has pictures, audio, & video.

Key facts about MapHabit

Founded Year: 2018
Location: Atlanta (United States)
Stage: Seed
Employee Count: 22 as on May 31, 2026
Investors: NIA, Georgia Research Alliance and 2 Others
Latest Funding Round: Grant (prize money), Jun 06, 2025, $*****
Highlight: Editors' Pick

5. iVivity

Key facts about iVivity

Founded Year: 2000
Location: Norcross (United States)
Stage: Deadpooled
Total Funding till date: $36M
Employee Count: 14 as on Apr 30, 2026
Investors: Kinetic Ventures, Grotech Ventures and 7 Others
Latest Funding Round: Series C, Sep 27, 2006, $*****

View the full list of portfolio companies

ATDC has invested in 9 companies over the last 20 years, with an average of 0 new investment annually in the last 10 years. Its most recent first time investment was in AvantiCure and most recent follow-on round was in Biofisica.

View all investments by ATDC

ATDC has made 3 investments in Seed stage, 2 investments in Series A stage with an average round size of $5M, 1 investment in Grant (prize money) stage with an average round size of $50K, 1 investment in Series B stage with an average round size of $2.5M and 1 investment in Series C stage with an average round size of $10M.

Here are ATDC's investments by stage:

Stage of entry	No. of Investments
Seed	3
Series A	2
Grant (prize money)	1
Series B	1
Series C	1

Note: We have considered here, only first round of investments

View all investments by ATDC

ATDC has a diverse portfolio, with companies operating in the Enterprise Applications, Life Sciences, Blockchain - Industry Applications, EdTech and Enterprise Infrastructure. Notably, it has invested in 8 Tech companies, 7 Enterprise (B2B) companies, 5 Software companies and at least 3 companies focusing on Consumer (B2C).

Here are ATDC's investments by sector:

Sector	No. of Investments
Enterprise Applications	4
Life Sciences	3
Blockchain - Industry Applications	1
EdTech	1
Enterprise Infrastructure	1
Others	3

Note: We have considered here, only first round of investments

View all investments by ATDC

ATDC has made most investments in United States (8).

View all investments by ATDC

ATDC has not made any investment in 2026 so far.

Here are the most recent investments by ATDC:

Filter this list

Date	Company	Location	Round Details	Round Amount	Co-Investors
Aug 12, 2019	AvantiCure	United States	Grant (prize money)	8529	-
Apr 13, 2019	MapHabit	United States	Seed	3106	-
Apr 19, 2017	UserIQ	United States	Series A	7436	-
Jan 07, 2009	Iconic Therapeutics	United States	Series B	3687	The City of New Haven [+1]
Nov 11, 2008	GlobalCrypto	United States	Seed	3244	Ridgewood Capital

See more recent investments made by ATDC

1 of ATDC's portfolio company became public - VTI. It got listed on the Australian Securities Exchange (ASX), in Mar 2017 at marketcap of $6.82M

Here are ATDC's portfolio companies that went public:

Filter this list

Company	IPO Date	First Invested on	First Round of Investment	Round Size
VTI	Mar 28, 2017	2008	Seed	2736

View more details about public companies in ATDC's portfolio

1 company from ATDC's portfolio has been acquired. The most recent acquisition was Iconic Therapeutics in Oct 2022 by Endpoint Health for $*****.

Here are ATDC's portfolio companies that got acquired most recently:

Filter this list

Company	Acquisition Date	First Invested on	First Round of Investment	Round Size
Iconic Therapeutics	Oct 04, 2022	Jan 07, 2009	Series B	9064

View all acquired companies in ATDC's portfolio

ATDC has a team of 29 members including 6 Partners, 4 Venture Partners and 12 Principals located in India, United States and 1 more location. ATDC's team does not sit on the board of any company as of now.

Here is a list of top team members in ATDC:

Name	Designation	Location	Board Memberships	Contact Details
Curt Williamson	Partner	Stoughton	-	1 Email
Geevarghese Kunjukutty	Partner	Kollam	-	1 Email
Juan C Valdes	Partner	Miami	-	1 Email
Brandi Taylor	Partner	Surprise	-	1 Email
Ted G	Partner	Brooklyn	-	1 Email
Faouzi Bh	Partner	Tunisia	-	1 Email
Sig Mosley	Venture Partner	Atlanta	-	3 Emails
Scott Ryan	Venture Partner	Atlanta	-	2 Emails
Chris Nedza	Venture Partner	Atlanta	-	1 Email
Ben Dyer	Venture Partner	Atlanta	-	-
Archna Atdc	Principal	Thane	-	1 Email

View team details of ATDC

Over the past 20 years, 29 investors have co-invested in ATDC's portfolio companies. This includes only funds.

Invested before ATDC: BIP Ventures, BLH Venture Partners and 11 others have invested in rounds before ATDC. There is 1 company where BIP Ventures has invested before ATDC and 1 company where BLH Venture Partners has invested before ATDC.
Top Co-investors of ATDC: 5 investors entered a company along with ATDC. These include investors like The City of New Haven (1 company).
Invested after ATDC: A total of 11 investors have invested in ATDC's portfolio after their investments. Top Investors include HBM Healthcare Investments (1 company) and Lundbeck Foundation (1 company).